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STUDY QUESTION: What changes have occurred in the incidence of miscarriage, its treatment options, and the proﬁle of the women
having miscarriages in Finland between 1998 and 2016?
SUMMARY ANSWER: The annual incidence of registry-identiﬁed miscarriage has declined signiﬁcantly between 1998 and 2016, and non-
surgical management has become the dominant treatment.
WHAT IS KNOWNALREADY:Miscarriage occurs in 8–15% of clinically recognized pregnancies and in∼30% of all pregnancies. Increasing
maternal age is associatedwith an increasing risk of miscarriage. The treatment of miscarriage has evolved signiﬁcantly in recent years: previously,
surgical evacuation of the uterus was the standard of care, but nowadays medical and expectant management are increasingly used.
STUDY DESIGN, SIZE, DURATION:We conducted a nationwide retrospective cohort study of 128 381 women that had experienced a
miscarriage that was managed in public healthcare between 1998 and 2016 in Finland.
PARTICIPANTS/MATERIALS, SETTING, METHODS: We used the National Hospital Discharge Registry for the data. Women aged
15–49 years that had experienced their ﬁrst miscarriage during the follow-up period and had miscarriage-related diagnoses during their
admission to public hospital were included in the study. Miscarriages were deﬁned by the 10th Revision of the International Statistical
Classiﬁcation of Diseases and related Medical Problems (ICD-10) diagnostic codes O02∗, O03∗ and O08∗. Women with ectopic, molar
and continuing pregnancies and induced abortions were excluded. Treatment was divided into surgical and non-surgical treatment using the
surgical procedure codes.
MAIN RESULTS AND THE ROLE OF CHANCE: The annual incidence of registry-identiﬁed miscarriage has declined from 6.8/1000 15–
49-year-old women in 1998 to 5.0/1000 in 2016 (P < 0.001). Also, the incidence rate of registry-identiﬁed miscarriage (i.e. the proportion of
miscarriages of registry-identiﬁed pregnancies [i.e. deliveries, induced abortions, and miscarriages]) has declined from 112/1000 15–49-year-
old pregnant women in 1998 to 83/1000 in 2016 (P< 0.001). The largest decrease in this proportion occurred among women over 40 years
of age, among whom 26.5% of registry-identiﬁed pregnancies in 1998 ended in miscarriage compared to that of 16.4% in 2016. The proportion
of missed abortion has increased (30.3 to 38.8%, P < 0.001) whereas that of blighted ovum has decreased (25.4 to 12.8%, P < 0.001). The
proportion of registry-identiﬁed miscarriages seen among nulliparous women has increased from 43.7 to 49.6% (P < 0.001). Mean age at the
time of miscarriage remained at 31 years throughout the study. Altogether, 29% of all miscarriages were treated surgically and 71% underwent
medical or expectant management. The proportion of surgical management has decreased from 38.0 to 1.6% for spontaneous abortion, from
60.7 to 9.4% for blighted ovum and 70.9 to 11.2% for missed abortion between 1998 and 2016.
LIMITATIONS, REASONS FOR CAUTION: This study includes only women with registry-identiﬁed pregnancies, i.e. women who were
treated in public hospitals. However, the number of women treated elsewhere is presumed to be small. Neither can this study estimate the
number of women having spontaneous miscarriage with no hospital contact.
WIDER IMPLICATIONS OF THE FINDINGS: Both the annual incidence and incidence rate of miscarriage of all registry-identiﬁed
pregnancies has decreased, and non-surgical management has become the standard of care. These ﬁndings are of value when planning allocation
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of healthcare resources and at individual level considering fertility andmiscarriage questions.We speculate that improving ultrasound diagnostics
explains the increasing proportion of missed abortion relative to other types of miscarriage. More investigation is needed to examine potential
risk factors, complications and morbidity associated with miscarriages.
STUDY FUNDING/COMPETING INTEREST(S): This study was funded by the research funds of the Helsinki and Uusimaa hospital
system, by a personal grant from Viipurin Tuberkuloosisäätiö to R.L. and by a personal grant from The Finnish Cultural Foundation to N.H.
The authors have no conﬂicts of interest to declare.
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Introduction
Approximately 8–15% of clinically recognized pregnancies end in a
miscarriage (Warburton and Fraser, 1964; Regan et al., 1989; Wang
et al., 2003) However, it has been estimated that about 30% of all
pregnancies result in a miscarriage. (Wilcox et al., 1988; Wang et al.,
2003; Griebel et al., 2005). Thus, miscarriage is the most common
adverse outcome of pregnancy (Jurkovic et al., 2013; Feodor Nilsson
et al., 2014). The majority of miscarriages occur in the ﬁrst trimester
of pregnancy (Regan and Rai, 2000).
The treatment of early miscarriage has evolved signiﬁcantly in recent
years. Previously, the standard treatment of miscarriage was surgical
evacuation of the uterus, but medical and expectant management is
now increasingly used (Graziosi et al., 2006; Smith et al., 2009). For a
long time, it was assumed that the surgical evacuation decreases the risk
of gynaecologic infection and haemorrhage. However, it has recently
been recognized that surgical management carries certain risks as well.
In a randomized controlled MIST trial performed in the UK, there were
no signiﬁcant differences in the rate of infections after surgical versus
expectant ormedical management of miscarriage (Trinder et al., 2006).
Medical management using misoprostol is the newest treatment option
and also recommended by the currentWHOguideline (Lemmers et al.,
2016b;World Health Organization, 2018). A recent randomized study
showed that pre-treatment with mifepristone prior to misoprostol
administration leads to better outcome and reduces the need for
subsequent uterine evacuation for retained products of conception
(Schreiber et al., 2018).
Following approval of mifepristone in several EU countries in the
early 2000s, the use of medically induced abortion has increased
rapidly, especially in northern European countries (Männistö et al.,
2013; THL (National Institute for Health andWelfare), 2019). Similarly,
medical management of miscarriage is being increasingly used (Zhang
et al., 2005). There are several studies concerning the use and out-
comes of medical termination of pregnancy, but much less has been
published concerning use of the various treatment options for miscar-
riage (Kulier et al., 2011;Wildschut et al., 2011; Al Wattar et al., 2019).
The aim of the present population-based study was to analyse the
proﬁle of women and the trends in incidence and proportions and in
treatment of miscarriage at a national level. To this end, we used the
high-quality Finnish healthcare registers between 1998 and 2016.
Materials and Methods
Study population and design
This nationwide retrospective cohort study included all miscarriages
managed in public hospitals in Finland between 1998 and 2016. Data
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were derived from the National Hospital Discharge Registry main-
tained by the National Institute for Health and Welfare. Miscarriage
was deﬁned based on the diagnostic codes (10th version of International
Classiﬁcation of Diseases and related Health Conditions, ICD-10):
O02∗, O03∗ and O08∗. Fertile-age women (15–49 years) who had
one or more miscarriages leading to inpatient or outpatient admission
to hospital were included in the study (Fig. 1). The ﬁrst miscarriage
during the follow-up period was studied.
In order to identify true miscarriages, women with the diagnostic
code of ectopic pregnancy (O00∗), molar pregnancy (O01∗), induced
abortions (O04∗, O05∗, O07∗) or continuing pregnancy (Z34∗) were
excluded (n =10 147). This was performed by comparing the ICD-
10 diagnostic codes at the time of miscarriage and during the 42 days
following the ﬁrst diagnosis. Women with note of a birth or an induced
abortion 42 days before or after the ﬁrst miscarriage diagnosis in the
Medical Birth Register (MBR) or Register of Induced Abortions (RIA)
were also excluded (Fig. 1).
Based on the diagnostic codes, miscarriages were classiﬁed into
four groups: blighted ovum (O02.0), missed abortion (O02.1),
spontaneous abortion (O03.9) and others (including e.g. incomplete
spontaneous abortion; incomplete spontaneous abortion, complicated
by delayed or excessive haemorrhage and complete or unspeci-
ﬁed spontaneous abortion, complicated by delayed or excessive
haemorrhage). We used MBR and RIA to identify the possible
previous deliveries and induced abortions. MBR was started in 1987
so we could not obtain any data before that year. The data from
RIA, about induced abortions, was gathered from the year 1998.
We had no information on the parity of altogether 132 women
(0.1%).
We further evaluated the trends in the treatment of registry-
identiﬁed miscarriage. The treatment procedures were divided into
surgical and non-surgical (medical or expectant). We identiﬁed
the surgical treatments using NOMESCO Classiﬁcation of Surgical
Procedures (NCSP) codes (Fig. 1). We included all codes indicative
of surgical treatment of miscarriage within 7 days and within 1 month
after the initial admission to the hospital. The expectant management
and medical treatment could not be reliably differentiated from each
other by using ICD-10 and NCSP codes, and thus, they were analysed
as one group.
Study approvals
We obtained an approval for this study from the National Institute
for Health and Welfare (THL/841/5.05.00/2017). The data were
anonymized prior to analyses. Because of the retrospective nature of
the register-based study, no approval was required from the local ethics
committee.
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Figure 1 Flow diagram of the study. The procedure codes, which deﬁned the surgical treatment were LCA10 (curettage of body of uterus),
LCA13 (curettage of cervix and body of uterus), LCA96 (other intrauterine operation), LCH00 (evacuation of retained products of conception;
vacuum aspiration or curettage), LCH03 (evacuation of products of conception and curettage of uterus), LCH13 (evacuation of retained products of
conception after medically induced abortion; vacuum aspiration or curettage), LCH15 (evacuation of retained products of conception after surgical
induced abortion; vacuum aspiration or curettage), LDA10 (curettage of cervix uteri), MBA00 (Vacuum aspiration from uterus after delivery or
abortion), MBA03 (curettage of uterus after delivery or abortion), MBA04 (curettage of uterus after delivery) and MBA05 (curettage of uterus
after abortion).
Statistical analyses
For the annual incidence of registry-identiﬁed miscarriage, we divided
the number of miscarriages by the total number of 15–49-year-old
fertile-aged women in Finland and the incidence rate by 15–49-year-
old pregnant women in Finland (women with pregnancy ending in birth,
induced abortion or miscarriage according to register-based data).
The chi-square test for trend was used to assess signiﬁcant trends in
proportions over the study period. The possible trend in average age
over time was examined using analysis of variance with linear trend
test. Correlations were tested using Spearman’s correlation coefficient.
Analyses were carried out with IBM SPSS Statistics 24.0 (Armonk, NY:
IBM Corp., USA).
Joinpoint Regression Program 4.7.0.0 (Statistical Research and
Applications Branch, National Cancer Institute, USA) was used
to analyse the miscarriage incidence trends. Joinpoint analysis
identiﬁes the best inﬂexion points at which the trend line changes
signiﬁcantly in direction or in magnitude using permutation tests.
The joinpoint analysis further generates the estimates of the annual
percentage change (APC) with 95% conﬁdence intervals (95% CI)
for the time segments. A signiﬁcance level of 0.05 was used for all
analyses.
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Results
Incidence of miscarriage
Between 1998 and 2016, we identiﬁed altogether 128 381 women
that had experienced miscarriage (Fig. 1). Table I shows the baseline
characteristics of the study subjects. Data on previous miscarriages and
induced abortions were obtained from MBR and RIA for women with
a history of delivery (n =69 561).
The annual incidence of registry-identiﬁed miscarriage has declined
from 6.8/1000 15–49-year-old women in 1998 to 5.0/1000 in 2016
(P < 0.001). Also, the incidence rate of registry-identiﬁed miscarriage
(i.e. the proportion of miscarriages of registry-identiﬁed pregnancies
[i.e. deliveries, induced abortions and miscarriages]) has declined from
112/1000 15–49-year-old pregnant women in 1998, to 83/1000 in
2016 (P< 0.001). The total number of miscarriages during the study
period in relation to registry-identiﬁed pregnancies and in different age
groups is presented in Fig. 2. Among women aged 40 years or more,
the incidence rate of miscarriage declined from 265/1000 registry-
identiﬁed pregnancies in 1998, to 164/1000 in 2016 (P < 0.001).
According to the joinpoint analyses, miscarriage incidence declined
signiﬁcantly during the study period. In relation to fertile-aged
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Table I Demographic characteristics according to time and age group (years).
Years Age group
Miscarriages, n
(% of group)
Parity % a
Induced abortions in
parous women % b
Miscarriages in parous
women %c
Mean age at
the time of
miscarriage
(SD)
....................... .................................... ....................................
0 ≥1 0 1 ≥2 0 1 ≥2
......................................................................................................................................................................................
1998–2001
15–19 1369 (4.4) 91.5 8.5 82.8 16.4 0.9 97.4 0.9 1.7 18.4
20–29 11 805 (38.2) 54.2 45.8 88 9.2 2.9 86.3 11.2 2.5 25.8
30–39 14 460 (46.8) 31.1 68.9 88.4 8.5 3.1 78 16.1 5.9 34.5
40–49 3263 (10.6) 39.4 60.6 89.3 7.7 3 62.3 22.6 15.1 42.5
Total n 30 897 13 401 17 437 14 599 1433 493 13 746 2647 1019 31.3 (6.6)
.....................................................................................................................................................................................
2002–2006
15–19 1669 (4.9) 91.2 8.8 77.6 19 3.4 93.9 6.1 0 18.5
20–29 13 651 (40.1) 56.5 43.5 82.8 12.7 4.5 92.8 5.9 1.3 25.8
30–39 15 354 (45.1) 33.3 66.7 83.4 11.3 5.2 85.2 11.4 3.4 34.6
40–49 3343 (9.8) 28.9 71.1 80.9 12.1 7 74.4 17.6 8 42.3
Total n 34 017 15 306 18 676 15 214 2190 954 16 117 1938 612 31.0 (6.6)
.....................................................................................................................................................................................
2007–2011
15–19 1457 (4.4) 91.7 8.3 81.8 15.7 2.5 95 5 0 18.6
20–29 13 327 (40.6) 57.8 42.2 80.5 14.4 5.1 94.2 5.1 0.7 25.8
30–39 14 821 (45.2) 35.8 64.2 82.3 12.3 5.4 90 8.2 1.8 34.3
40–49 3184 (9.7) 28.8 71.2 76.6 15.1 8.3 79.7 15.4 4.9 42.3
Total n 32 789 15 260 17 497 14 101 2330 982 15 754 1415 322 31.0 (6.5)
.....................................................................................................................................................................................
2012–2016
15–19 1142 (3.7) 93.5 6.5 79.7 16.2 4.1 100 0 0 18.6
20–29 11 753 (38.3) 57.8 42.2 79.8 14.4 5.8 92.4 6.4 1.2 25.9
30–39 14 893 (48.5) 39.8 60.2 81.4 12.6 6 90.9 7.5 1.6 34.3
40–49 2890 (9.4) 32.5 67.5 74.8 15.8 9.4 84.4 11.9 3.7 42.3
Total n 30 678 14 721 15 951 12 756 2158 1011 14 448 1224 272 31.3 (6.4)
aParity data missing (n =132, 0.10%)
bInduced abortion data missing (n =1340, 1.9% of delivered women)
cMiscarriage data missing (n =47, 0.068%)
Figure 2 Miscarriages in relation to registry-identiﬁed pregnancies (i.e.deliveries+miscarriages+ induced abortions) over time
according to age groups.
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Figure 3 Distribution over time of miscarriage types: blighted ovum and non-hydatidiform mole,missed abortion, spontaneous
abortion and other diagnosis (such as incomplete spontaneous abortion, incomplete spontaneous abortion; complicated by
delayed or excessive haemorrhage, and complete or unspeciﬁed spontaneous abortion; complicated by delayed or excessive
haemorrhage).
Figure 4 Miscarriages according to parity over time.
women time segments were 1998–2001, 2001–2013 and 2013–2016.
APCs were −5.0 for 1998–2001 (95% CI [−7.1, −2.1]), −0.5 for
2001–2013 (95% CI [−0.8, −0.1] and −3.1 for 2013–2016 (95% CI
[−5.7, −0.5] (P < 0.001). The inﬂexion points were years 2001 and
2013. In relation to pregnant women, time segments were 1998–2001,
2001–2007 and 2007–2016. APCs were −4.5 for 1998–2001 (95% CI
[−6.4, −2.6]) (P < 0.001), −1.8 for 2001–2007 (95% CI [−2.7, −0.8]
(P < 0.001) and −0.4 for 2007–2016 (95% CI [−0.8, 0.1] (P =0.1).
With time segment 1998–2016, APC was −1.5 (95% Cl [−2.0, −1.1])
(P < 0.001).
The number of miscarriages managed in public hospitals declined
over time; there were 8440 women with registry-identiﬁed miscarriage
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in 1998 and 5673 women in 2016 (P < 0.001). The annual number of
all miscarriages did not correlate signiﬁcantly with the total number of
registry-identiﬁed pregnancies (rs = 0.158, P =0.519). The mean age
at the time of miscarriage (mean 31.2 [SD 6.5]) remained unchanged
during the study period (P=0.639; Table I). Of the 30 897miscarriages
registered in 1998–2001, 4.4, 38.2, 46.8 and 10.6% of miscarriages
occurred in women in aged 15–19, 20–29, 30–39 and 40–49 years
of age, respectively. This pattern did not change substantially over the
years.
In the age groups of underlying population of pregnant women, there
were some changes during the time frame of our study. In 1998–2001,
57/1000 pregnant womenwere 15–19-year-old, and in 2012–2016 the
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Figure 5 Trend over time in surgical treatment (within 7 days of initial admission) according to miscarriage type.
rate was 38/1000 (P < 0.001). For the 20–29-year-old women, the
corresponding rates were 459/1000 and 447/1000 (P < 0.001), for
30–39-year-old women 440/1000 and 471/1000 (P < 0.001) and for
the women aged 40 years or more 44/1000 and 45/1000 pregnant
women (P =0.745).
Miscarriage types
The proportion of blighted ovum of all miscarriages decreased from
25.4% in 1998 to 12.8% in 2016. In contrast, the proportion of missed
abortion has increased from 30.3 to 38.8% and that of spontaneous
abortion from 20.8% in 1998 to 27.3% in 2016 (P < 0.001; Fig. 3).
Miscarriage and parity
Miscarriages were more common among nulliparous than among
parous women as we categorized women in three groups: nulliparous
women, women with history of one delivery and women with more
than one deliveries. The proportion of all miscarriages among registry-
identiﬁed pregnancies in 1998 was as follows: 43.7% occurred among
nulliparous women, 26.4% occurred among women with a history
of one delivery and 29.8% occurred among women with a history of
more than one delivery. In 2016, these proportions increased to 49.6%
among nulliparous women (P< 0.001), increased to 26.7% among
women with a history of one delivery (P< 0.001) and decreased
to 23.8% among women with a history of more than one delivery
(P< 0.001) (Fig. 4).
Treatment of miscarriage
Over the entire study period, altogether 29% underwent surgical
treatment and 71% medical or expectant management within the
ﬁrst week of miscarriage diagnosis (Fig. 1). Of the surgically treated
women, 1.4% had more than one procedural code. Surgery was the
dominant means of treatment before the year 2002, but thereafter its
use has decreased (P < 0.001). In 1998, 57.7% of women received
surgical treatment, whereas in 2016 only 9.6% underwent surgical
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treatment within 7 days of the initial admission. Within 1 month, the
corresponding proportions were 58.9% in 1998 and 13.0% in 2016.
The women experiencing spontaneous abortion received less sur-
gical management compared to women that had blighted ovum and
missed abortion. In 1998, 38.0% of the women that experienced
spontaneous abortion were treated surgically within the ﬁrst week
of miscarriage diagnosis whereas 60.7% of the women with blighted
ovum and 70.9%withmissed abortion underwent surgical treatment. In
2016, the corresponding ﬁgures were 1.6, 9.4 and 11.2%, respectively
(P for trend <0.001). The proportion of surgical treatment within
1 month in 1998 and 2016 was 39.0 and 2.4% for spontaneous
abortion, 63.3 and 15.2% for blighted ovum and 72.0 and 16.1% for
missed abortion (P for trend<0.001). Figure 5 displays the proportion
of women undergoing surgical treatment within 1 week according to
the type of miscarriage between 1998 and 2016. The corresponding
proportions for surgical treatment within 1 month are demonstrated in
Supplementary Figure S1.
Discussion
This nationwide register-based study shows that the incidence, the inci-
dence rate and the number of registry-identiﬁed miscarriages managed
in public healthcare have diminished, and the proportion of surgical
treatment of miscarriage has declined during 1998 to 2016. Overall, in
1998, 11.2% of registry-identiﬁed pregnancies resulted in miscarriage;
in 2016, their proportion was 8.3%. To our knowledge, the present
study is the ﬁrst large study that has noted an overall declining incidence
rate of miscarriage.
In accordance with other studies, our study demonstrates increasing
incidence of miscarriage with increasing maternal age in women aged
more than 30 years and very clearly in women aged 40 years or more
(Nybo Andersen et al., 2000; Feodor Nilsson et al., 2014). However, it
is remarkable that among women aged 40 years or more, the incidence
rate of miscarriage has declined from 265/1000 registry-identiﬁed
pregnancies in 1998 to 164/1000 in 2016. On the other hand, the
underlying population of women aged 40 or more has diminished,
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but that should not affect the incidence rate of miscarriage in this
group over time. Additionally, in Finland there is a lack of cycle-
based register on assisted reproductive treatments (ARTs); it is thus
impossible to determine its effects on the miscarriages in the current
study. Comparison to other countries is challenging due to a limited
number of studies of a similar kind. A recent Norwegian register-
based study demonstrated, according to expectations, that the risk of
miscarriage is highest in women aged 45 years or more, but the risk
is also slightly increased among women aged under 20 years (Magnus
et al., 2019).
Missed abortion was the dominant type of miscarriage, and its
proportion has increased. Conversely, the proportion of blighted ovum
has clearly decreased. A possible explanation for this might be the
enhanced quality of ultrasound scans used, providing better detection
rate of the foetal pole in early pregnancy.
A recent study from Israel concluded that the rate of miscar-
riage increases according to women’s parity (Cohain et al., 2017).
In contrast, we found that the proportion of all registry-identiﬁed
miscarriages seen among nulliparous women (43.7% in 1998, 49.6%
in 2016) was higher than the proportions among women with history
of one delivery (26.4% in 1998, 26.7% in 2016) or more than one
delivery (29.8% in 1998, 23.8% in 2016). Thus, if nulliparous and
parous women are compared, less than half of all registry-identiﬁed
miscarriages occurred among nulliparous women. The number of
deliveries in Finland has decreased particularly after 2010, and thus,
the number of intended pregnancies has probably also declined in
both groups. On the other hand, the voluntary childlessness is esti-
mated to be increasing. A US study found no association between
parity and incidence of miscarriage (Sundermann et al., 2017). Of
course, the increasing average age of primigravidas can be one rea-
son for the increasing proportion of miscarriages among nulliparous
women.
The use of surgical treatment of miscarriage has diminishedmarkedly
in all types of miscarriages examined. This might be explained, for
example, by the higher costs and lower availability of surgical com-
pared to medical treatment or expectant management. The medical
management of miscarriage is also often recommended by health
professionals in Finland. Similarly, the use of medical management for
induced abortion has increased from 10.6% in 2000, to 97.7% in 2017
(THL (National Institute for Health and Welfare), 2019). Moreover,
the invasive nature of surgical management with associated risks might
be less appealing to women. Especially surgical treatment with general
anaesthesia, as it usually is performed in Finland, has been stated to
be more expensive than medical treatment of miscarriage (Rausch
et al., 2012). Nevertheless, in a randomized study comparing the cost-
effectiveness in medical and surgical treatment of miscarriage, the
difference in cost-effectiveness diminished when adverse events after
primary management were taken into account (Niinimäki et al., 2009).
There is a general agreement in the literature that non-surgical treat-
ment of miscarriage is somewhat less effective than surgical treatment
of miscarriage (Wieringa-de Waard et al., 2002; Niinimäki et al., 2006;
Trinder et al., 2006). Regardless, surgical treatment of miscarriage has
recently been associated with subsequent preterm birth (Lemmers
et al., 2016a). A higher risk of infection has also been connected to
surgical treatment (Niinimäki et al., 2006). We found a higher use of
conservative treatment in the management of spontaneous abortion
throughout the study period, whereas surgical treatment of missed
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miscarriage declined remarkably from 70.9 to 11.2% and blighted ovum
from 60.7 to 9.4%.
The present study has considerable strengths. The large study sample
and the high number of miscarriages enabled reliable estimation of the
trends in miscarriages at a national level. In addition, the Finnish reg-
isters allowed the combination and linking of the register information.
The high quality of the Finnish register data is also a strength of the
study (Gissler and Haukka, 2004).
This study also has limitations. First of all, the present study relies
on registry data, which were used to identify miscarriages. The
registers have information only for those miscarriages diagnosed
and treated in the public specialized healthcare, and thus, women
with early post-implantation pregnancy losses are likely not to be
included in the study. Conversely, the proportion of miscarriages
treated elsewhere is estimated to be relatively small as all Finnish
residents are entitled to treatment in the public healthcare system
and are charged the same low user fee. The determination of
accurate proportions is difficult, but for example only 1% of all
induced abortions are performed in private settings (THL National
Institute for Health and Welfare, Register on Induced Abortion,
unpublished data). In addition, we studied the number of miscarriages
in relation to registry-identiﬁed pregnancies (i.e. miscarriages, births
and induced abortions); however, ectopic and molar pregnancies
were not included. The surgical procedure codes have changed
in time, so it was necessary to use both older and new codes in
deﬁning surgical and non-surgical treatment. Medical and expectant
management could not be separated reliably enough with the
use of procedural codes, because there is no procedural code
for expectant management and the procedural code for medical
management is often not used. Therefore, the distinction between
these two methods of treatment could not be made. Furthermore,
some of the women might have experienced a miscarriage before
the year 1998 and it is not possible to identify these women
because in Finland the codes for diagnoses and procedures of the
outpatient appointments were registered 1998 onwards. Also, it
was not possible to clarify the multiple pregnancies, the duration
of gestation at the time of miscarriage diagnosis or the socioe-
comonic status of the women as these data are not included in
the registries used.
In conclusion, the present study demonstrates national trends in a
large scale—both the incidence and the incidence rate of registry-
identiﬁedmiscarriage have decreased, and the treatment of miscarriage
is increasingly non-surgical. These ﬁndings are of value when planning
allocation of healthcare resources. For instance, the use of surgical
evacuation, previously performed under general anaesthesia and also
during late hours, is nowadays a rarity. This is likely to reduce the need
for operating room resources and thereby reduce healthcare costs.
At the individual level, these ﬁndings are of value while counselling
women or couples with miscarriage- or fertility-related questions. In
addition, formation of the present nationwide cohort of miscarriage
allows for further register linkages to examine the associated general
and reproductive health outcomes of miscarriage.
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